Home › Funds › Spruce Street Capital LP › ENTX
Spruce Street Capital LP position in ENTX
ENTERA BIO LTD · Health Care
Spruce Street Capital LP reported holding 11,213,455 shares of ENTX (ENTERA BIO LTD) in its Q3 2026 13F filing — a position valued at US$32.6M, representing 5.19% of its reported portfolio and ranking #6 among its reported holdings. Spruce Street Capital LP first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Spruce Street Capital LP's ENTX position evolved
Spruce Street Capital LP first disclosed a stake in ENTX in Q3 2026 at 11,213,455 shares (US$32.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 11.21M | $32.63M | New |
About ENTX and 13F data
ENTX (ENTERA BIO LTD) is a Health Care company. 33 other funds we track also report a position in ENTX — the largest reported positions include Vivo Capital, LLC (US$35.7M), Knoll Capital Management, LLC (US$10.4M), NEXTBio Capital Management LP (US$8.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTX
- Vivo Capital, LLC 12.25M sh · $35.66M · Q3 2026
- Knoll Capital Management, LLC 5.88M sh · $10.41M · Q2 2026
- NEXTBio Capital Management LP 2.92M sh · $8.51M · Q3 2026
- BVF INC/IL 2.42M sh · $4.29M · Q2 2026
- Gem Investment Advisors, LLC 19.14K sh · $55.68K · Q3 2026
More on Spruce Street Capital LP
FAQ
How long has Spruce Street Capital LP held ENTX?
Spruce Street Capital LP has disclosed ENTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Spruce Street Capital LP's current position in ENTX?
As of Q3 2026, Spruce Street Capital LP holds 11.21M shares of ENTX (ENTERA BIO LTD), valued at $32.63M, representing 5.19% of its reported portfolio and ranking #6.
Has Spruce Street Capital LP been buying or selling ENTX?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP newly opened its position in ENTX.
Which other funds hold ENTX?
Other major institutional holders of ENTX include Vivo Capital, LLC, Knoll Capital Management, LLC, NEXTBio Capital Management LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.